Literature DB >> 20473726

[Neoadjuvant treatment and breast conserving surgery - a success of clinical research in breast cancer].

Michael Gnant1.   

Abstract

Breast cancer is, with more than 5200 newly diagnosed cases, the most frequent malignancy of women in Austria. Screening programs have helped to improve early detection and breast conservation, also clinical trials have made possible some decisive progress in breast cancer treatment. For women affected it is of utmost importance that we meanwhile can offer breast-conserving surgery also for large tumors without risking more local recurrences. The trials of the ABCSG, particularly those dealing with neoadjuvant therapy, were instrumental in this development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20473726     DOI: 10.1007/s10354-010-0762-9

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  11 in total

Review 1.  Primary chemotherapy for breast cancer: the evidence and the future.

Authors:  M S Mano; A Awada
Journal:  Ann Oncol       Date:  2004-08       Impact factor: 32.976

2.  Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.

Authors:  Manfred Kaufmann; Gabriel N Hortobagyi; Aron Goldhirsch; Suzy Scholl; Andreas Makris; Pinuccia Valagussa; Jens-Uwe Blohmer; Wolfgang Eiermann; Raimund Jackesz; Walter Jonat; Annette Lebeau; Sibylle Loibl; William Miller; Sigfried Seeber; Vladimir Semiglazov; Roy Smith; Rainer Souchon; Vered Stearns; Michael Untch; Gunter von Minckwitz
Journal:  J Clin Oncol       Date:  2006-04-20       Impact factor: 44.544

3.  Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen.

Authors:  Aman U Buzdar; Vicente Valero; Nuhad K Ibrahim; Deborah Francis; Kristine R Broglio; Richard L Theriault; Lajos Pusztai; Marjorie C Green; Sonja E Singletary; Kelly K Hunt; Aysegul A Sahin; Francisco Esteva; William F Symmans; Michael S Ewer; Thomas A Buchholz; Gabriel N Hortobagyi
Journal:  Clin Cancer Res       Date:  2007-01-01       Impact factor: 12.531

4.  Breast-conserving therapy for centrally located breast cancer.

Authors:  Florian Fitzal; Martina Mittlboeck; Herwig Trischler; Wilfried Krois; Greta Nehrer; Maria Deutinger; Raimund Jakesz; Michael Gnant
Journal:  Ann Surg       Date:  2008-03       Impact factor: 12.969

Review 5.  Breast-conserving surgery in the neoadjuvant setting.

Authors:  D R Brenin; M Morrow
Journal:  Semin Oncol       Date:  1998-04       Impact factor: 4.929

6.  Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group.

Authors:  Raimund Jakesz; Hellmut Samonigg; Michael Gnant; Ernst Kubista; Dieter Depisch; Roland Kolb; Brigitte Mlineritsch; Hans-Jörg Mischinger; Rainer-Christian Menzel; Peter Steindorfer; Werner Kwasny; Christoph Tausch; Michael Stierer; Susanne Taucher; Michael Seifert; Hubert Hausmaninger
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

7.  Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14.

Authors:  Günther G Steger; Arik Galid; Michael Gnant; Brigitte Mlineritsch; Alois Lang; Christoph Tausch; Margaretha Rudas; Richard Greil; Catharina Wenzel; Christian F Singer; Anton Haid; Sabine Pöstlberger; Hellmut Samonigg; Gero Luschin-Ebengreuth; Werner Kwasny; Eduard Klug; Ernst Kubista; Christian Menzel; Raimund Jakesz
Journal:  J Clin Oncol       Date:  2007-05-20       Impact factor: 44.544

8.  Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.

Authors:  Richard Pötter; Michael Gnant; Werner Kwasny; Christoph Tausch; Leonore Handl-Zeller; Brigitte Pakisch; Susanne Taucher; Josef Hammer; Gero Luschin-Ebengreuth; Marianne Schmid; Felix Sedlmayer; Michael Stierer; Georg Reiner; Karin Kapp; Friedrich Hofbauer; Andrea Rottenfusser; Sabine Pöstlberger; Karin Haider; Wolfgang Draxler; Raimund Jakesz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-23       Impact factor: 7.038

9.  Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast.

Authors:  U Veronesi; R Saccozzi; M Del Vecchio; A Banfi; C Clemente; M De Lena; G Gallus; M Greco; A Luini; E Marubini; G Muscolino; F Rilke; B Salvadori; A Zecchini; R Zucali
Journal:  N Engl J Med       Date:  1981-07-02       Impact factor: 91.245

10.  Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

Authors:  Priya Rastogi; Stewart J Anderson; Harry D Bear; Charles E Geyer; Morton S Kahlenberg; André Robidoux; Richard G Margolese; James L Hoehn; Victor G Vogel; Shaker R Dakhil; Deimante Tamkus; Karen M King; Eduardo R Pajon; Mary Johanna Wright; Jean Robert; Soonmyung Paik; Eleftherios P Mamounas; Norman Wolmark
Journal:  J Clin Oncol       Date:  2008-02-10       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.